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The Visual Impairment Intracranial Pressure (VIIP) syndrome is currently NASA’s number one human space 
flight risk.  The syndrome, which is related to microgravity exposure, manifests with changes in visual 
acuity (hyperopic shifts, scotomas), changes in eye structure (optic disc edema, choroidal folds, cotton 
wool spots, globe flattening, and distended optic nerve sheaths).  In some cases, elevated cerebrospinal 
fluid pressure has been documented postflight reflecting increased intracranial pressure (ICP).  While the 
eye appears to be the main affected end organ of this syndrome, the ocular affects are thought to be 
related to the effect of cephalad fluid shift on the vascular system and the central nervous system.  The 
leading hypotheses for the development of VIIP involve microgravity induced 
head-ward fluid shifts along with a loss of gravity-assisted drainage of venous blood from the brain, both 
leading to cephalic congestion and increased ICP.  Although not all crewmembers have manifested clinical 
signs or symptoms of the VIIP syndrome, it is assumed that all astronauts exposed to microgravity have 
some degree of ICP elevation in-flight.  Prolonged elevations of ICP can cause long-term reduced visual 
acuity and loss of peripheral visual fields, and has been reported to cause mild cognitive impairment in the 
analog terrestrial population of Idiopathic Intracranial Hypertension (IIH).  These potentially irreversible 
health consequences underscore the importance of identifying the factors that lead to this syndrome and 
mitigating them. 
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The integrated VIIP program that has been developed includes efforts to decrease environmental 
contributing factors such as elevated carbon dioxide levels onboard the ISS and sodium levels in space 
foods (operational efforts), development of Clinical Practice Guidelines for guiding diagnosis and 
treatment of affected crewmembers (clinical efforts), data mining of previously collected data to find 
patterns of susceptibility to VIIP development (occupational surveillance efforts), and a research program 
which includes flight studies, bed rest studies, animal studies, and studies on analogous terrestrial 
populations to elucidate the underlying mechanisms leading to VIIP, evaluate technologies to allow safe 
invasive and noninvasive intracranial pressure measurements, and test potential countermeasures 
(research efforts).  
Suspected pathophysiological mechanisms leading to VIIP clinical manifestations.  
    1) Cephalad fluid shifts and loss of gravity assisted venous drainage from the brain leads to:      
    2) increased ICP, which is manifested with: 
    3) Structural and functional changes to the eye.  
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Resistive Exercise 
Does in-flight resistive training 
cause additional transient 
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Prepackaged foods high in sodium 
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• CO2 is an extremely potent 
vasodilator  
• CO2 mission average = 10x 
normal sea level atmospheric 
• CO2 also known to increase 
CSF production 
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NASA’s Human Research Program, via the Human Health and Countermeasures Element, has established the VIIP 
Research Project, which is investigating etiology, technology, analogs, and potential countermeasures 
encompassing over 70 current, planned, and completed studies, of which about 25 are currently in progress. 
These studies are aimed at understanding the interaction of the microgravity environment with the ocular, 
cardiovascular, and central nervous systems.  
 
The operational and research communities at NASA are working collaboratively in an effort to understand the 
mechanisms causing the VIIP syndrome and to provide mitigation and countermeasures. The Medical Operations 
division (MedOps) has instituted extensive preflight, in-flight and postflight testing as part of occupational 
surveillance. Pre- and postflight tests include functional eye exams (vision testing), structural eye exams 
(fundoscopy, ocular ultrasound, optical coherence tomography [OCT] and biomicroscopy), intraocular pressure 
(tonometry), and eye, brain, and cerebraovascular anatomy via magnetic resonance imaging (MRI). The Ocular 
Health study, a prospective investigation, aims to define the temporal pattern for the appearance of signs and 
symptoms, delineate the association between duration of weightlessness and severity of symptoms (i.e., the 
dose-response), establish preflight baseline characteristics, characterize the nature of in-flight changes, and 
document changes from pre to postflight. The study expands upon inflight medically required data collection with 
the addition of additional time points, cardiovascular compliance (via ultrasound with concurrent ECG and blood 
pressure), and noninvasive intracranial pressure (via pulsatility index, measured by transcranial Doppler [TCD]).  
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